Search the Newsreel

Precision Biosciences Inc (DTIL) CFO details stock and major RSU grants

Naresh Haresh Tanna, the Chief Financial Officer of Precision Biosciences Inc (DTIL), has reported his direct ownership of 25,575 shares of common stock. Additionally, he received several Restricted Stock Unit (RSU) grants totaling 16,683, 33,317, 45,000, and 179,340 units, which will vest in three …

Precision Biosciences (DTIL) officer details stock and RSU holdings

Mei Zhang Lu, Chief Accounting Officer of Precision Biosciences Inc. (DTIL), has reported her direct ownership of 5,115 shares of common stock. Additionally, her holdings include fully vested employee stock options for 2,340 shares with various exercise prices and expiration dates, and restricted stock …

H.C. Wainwright reiterates Precision BioSciences stock rating at buy By Investing.com

H.C. Wainwright has reiterated a Buy rating and a $60.00 price target for Precision BioSciences Inc. (NASDAQ: DTIL) following a management meeting. The firm highlighted the company's strong cash position relative to debt and upcoming catalysts in late 2026 for its clinical programs targeting …

Precision BioSciences (DTIL) CSO discloses stock and RSU awards

Precision BioSciences' Chief Scientific Officer, Cassandra Louise Gorsuch, has disclosed her equity holdings in the company. The report details her direct ownership of 16,028 shares of Common Stock, fully vested employee stock options covering 820 shares, and Restricted Stock Units (RSUs) for a total …

Trading the Move, Not the Narrative: (VPG) Edition

This article provides an AI-generated analysis for Vishay Precision Group Inc. (NYSE: VPG), highlighting weak near and mid-term sentiment despite a long-term positive outlook. It details specific trading strategies for different risk profiles, including position, momentum breakout, and risk hedging, along with multi-timeframe signal …

Jiangxi Tungsten Rare and Precious Equipment在拟议收购中调整了业绩目标

253,066 Shares in CoreCivic, Inc. $CXW Acquired by Empowered Funds LLC

Empowered Funds LLC recently acquired 253,066 shares of CoreCivic, Inc. (NYSE:CXW) during the first quarter, a stake valued at approximately $4.8 million. This acquisition represents about 0.26% of CoreCivic, with institutional investors collectively owning 85.13% of the company. CoreCivic, a real estate investment trust …

Salt Funds Group Takes 5.45% Stake in Precinct Properties

POCI|Precision Optics Corporation Inc|Price:4.250|Chg%:+0.010

Vishay Precision to Report Q2 Earnings: What's in Store for the Stock?

Golden Prospect Precious Metals Limited Revenue Breakdown – LSE:GPM

(TFPM) Price Dynamics and Execution-Aware Positioning

This article analyzes Triple Flag Precious Metals Corp. (TFPM) stock, highlighting a near-term neutral sentiment amidst mid and long-term strength. It identifies a strong risk-reward setup targeting a 17.4% gain with minimal risk, and presents AI-generated trading strategies for various risk profiles. The analysis …

Precipio Schedules Q2 2026 Shareholder Update Call

Precipio (PRPO) announced it will host its Q2 2026 shareholder update call on August 17, 2026, at 5:00 p.m. ET to discuss performance in its cancer diagnostics businesses. CEO Ilan Danieli will provide remarks on progress and engage in a live Q&A session. TipRanks' …

Wheaton Precious Metals Aktie: Q2-Zahlen am Donnerstag erwartet

Precigen, Inc. Revenue Breakdown – NASDAQ:PGEN

CoreCivic, Inc. $CXW Stock Holdings Decreased by Bank of New York Mellon Corp

Bank of New York Mellon Corp decreased its stake in CoreCivic, Inc. (NYSE:CXW) by 7.6% in the first quarter, selling 50,021 shares and retaining 606,141 shares valued at $11.46 million. Despite this reduction, other institutional investors significantly increased their holdings, and institutional investors collectively …

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Average Recommendation of "Moderate Buy" by Analysts

ETFs Investing in Vishay Precision Group, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Vishay Precision Group, Inc. (VPG) stocks, providing financial details for each fund. The ETFs are sorted by market value and include information such as weight of VPG stock, issuer, management style, expense ratio, AUM, …

VPG Price Today: Vishay Precision Group, Inc. Stock Price, Quote & Chart | MEXC

This article provides a detailed overview of Vishay Precision Group, Inc. (VPG) stock performance and key financial data as of August 3, 2026. It highlights the current stock price, market capitalization, recent price changes, and historical performance over the past month and year. The …

Vishay Precision Group Number of Employees 2026 | Employee Count & Headcount Data

Vishay Precision Group (VPG) had approximately 2,084 employees worldwide as of March 2026, representing a 0.7% decline since 2023. The company is actively hiring, though job postings fell by 88.2% in 2026 compared to 2025. VPG's workforce is concentrated in South Asia (42.6%), North …

Precigen Insider Sold Shares Worth $606,000, According to a Recent SEC Filing

An insider at Precigen, Inc. sold shares valued at $606,000, as reported in a recent SEC filing. This transaction follows other recent insider share sales by the company, including sales worth $1,113,143 and $2,042,864 in early July. Precigen is a biopharmaceutical company focused on …

Cole G Carter (CXW) files to sell 12,500 LPL Financial shares

Cole G Carter, associated with CoreCivic (CXW), has filed to sell 12,500 shares of LPL Financial common stock, with an aggregate market value of $370,125.00. This planned sale is supported by an RSU vesting event on March 6, 2024, involving 73,953 shares, and follows …

Praxis Precision Medicines (PRAX) Projected to Announce Earnings on Monday

Wheaton Precious Metals Corp Actuals & Estimates (TSX:WPM)

This article provides an overview of Wheaton Precious Metals Corp (TSX:WPM) stock, including its current price, market capitalization, volatility, and historical performance. It also details financial actuals and analyst estimates for earnings and revenue, dividend information, and upcoming earnings report dates, concluding with analyst …

Precipio Inc (PRPO) Financial Health: Profitability & Balance Sheet Analysis

Precipio Inc (PRPO) has a weak financial status with a score of 4.51, ranking 199 out of 200 in its industry. Despite this, the company reported a significant year-over-year revenue increase of 36.15% and a net profit increase of 63.24% in its latest quarter. …

Precision BioSciences Inc (DTIL) Valuation: PE, PB & Fair Value Analysis

Precision BioSciences Inc (DTIL) currently holds a valuation score of 7.84, placing it 140th out of 385 in the Biotechnology & Medical Research industry. The company's current P/E ratio is -3.33, which is significantly below its recent high and above its recent low. Key …

Precipio (NASDAQ: PRPO) plans Q2 2026 shareholder call with live Q&A

Precipio, Inc. (NASDAQ: PRPO) announced it will host a Q2-2026 shareholder update call on August 17, 2026, at 5:00 PM ET. The call will cover updates on the company's core businesses and include a live moderated Q&A session. CEO Ilan Danieli expressed optimism about …

Precigen (NASDAQ: PGEN) CFO sells 100,000 shares in 10b5-1 plan

Precigen's Chief Financial Officer, Harry Thomasian Jr., sold 100,000 shares of common stock on July 31, 2026, under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $6.06, totaling approximately $606,000. Following this transaction, Thomasian Jr. directly holds …

PGEN (PGEN) insider outlines planned sale of 100,000 common shares

Harry Thomasian Jr., an insider at Precigen, Inc. (PGEN), has announced plans to sell 100,000 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $605,609.66. These shares are related to restricted stock vesting on August 28, 2024. This …

Precipio Inc. Q2 Results: Shareholder update call set for August 17

Precipio Inc. has scheduled its Q2-2026 shareholder update call for August 17, 2026, at 5:00 PM ET. CEO Ilan Danieli will discuss core business updates and progress in customer acquisition and pipeline expansion. Investors can participate in a live Q&A session or submit questions …

DTIL|Precision BioSciences Inc|Price:6.990|Chg%:-0.010

This article provides a comprehensive stock analysis of Precision BioSciences Inc (DTIL), highlighting its strong fundamentals, high growth potential, and "Strong Buy" analyst rating. Despite recent weak stock market performance, the company is developing gene editing therapies using its proprietary ARCUS platform and is …

Form 144 CoreCivic For: 31 July By Investing.com

The article "Form 144 CoreCivic For: 31 July By Investing.com" is a brief notice from Investing.com confirming the filing of a Form 144 for CoreCivic (CXW) on July 31st. It provides no further details about the Form 144 itself, only listing the company name …

Wheaton Precious Metals Falls as Investors Appear to Brace for Weaker Metals Sentiment and Upcoming Earnings

Wheaton Precious Metals (WPM) saw a 3.8% decline, likely due to broader sector pressure and investor positioning ahead of its Q2 2026 earnings release on August 6. The company's stock is highly sensitive to gold and silver prices, and recent analyst target reductions amid …

Precision Optics Corporation, Inc. Revenue Breakdown – NASDAQ:POCI

Precision Optics Corporation, Inc. (NASDAQ: POCI) generated the majority of its revenue from the United States, contributing $19.09 million USD last year and $19.10 million USD the year prior. This data highlights the company's primary market for its revenue streams. The information is provided …

Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026

Precision BioSciences, Inc. announced that it will release its second-quarter 2026 financial results and provide a business update on Thursday, August 6, 2026. The company is a clinical-stage gene editing firm utilizing its ARCUS® platform to develop in vivo gene editing therapies for various …

Precision BioSciences Inc (DTIL) Institutional Confidence

Precision BioSciences Inc (DTIL) has an institutional shareholding score of 5.00, placing it 132nd in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 60.88%, a significant increase of 64.56% quarter-over-quarter. James Simons is the largest institutional shareholder, though his holding percentage …